Stem Cell Eye Therapy Shows Promise
Reporting in The Lancet, researchers write that a preliminary study shows embryonic stem cell therapy in two patients with macular degeneration was safe. Results suggest the patients' vision improved slightly. Dr. Robert Lanza, Chief Scientific Officer of Advanced Cell Technology and co-author of the study, discusses the trial.
[Read the full article here]Related News:
Stem cell leaders Lanza, Kim win $1.9M NIH award
Firm seeks OK for stem cell clinical trial
Stem cell therapy shows promise for stroke